Loading...

Halozyme Therapeutics, Inc.

HALO•NASDAQ
Healthcare
Biotechnology
$58.24
$-0.53(-0.90%)

Halozyme Therapeutics, Inc. (HALO) Stock Chart & Performance Analysis

Explore Halozyme Therapeutics, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-4.86%
5-Day Change
-4.97%
1-Month Change
-6.09%
3-Month Change
9.28%
6-Month Change
10.68%
Year-to-Date (YTD) Change
20.18%
1-Year Change
46.89%
3-Year Change
39.44%
5-Year Change
220.20%
All-Time (Max) Change
1257.65%

Analyzing Halozyme Therapeutics, Inc. (HALO) Trends Across Multiple Time Frames

Halozyme Therapeutics, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Halozyme Therapeutics, Inc. stock shows -4.86% 1-day change, indicating low volatility, while its 5-day change of -4.97% suggests a broader trend. Over a 1-month period, a -6.09% drop could signal a pullback, whereas a 3-month rise of 9.28% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 10.68% and a YTD rise of 20.18% might concern investors, but a 1-year gain of 46.89% and a 3-year increase of 39.44% could indicate resilience. The 5-year surge of 220.20% highlights strong historical growth, while the all-time return of 1257.65% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;